A Phase Ib/ Ⅱ Clinical Study of MIL62 in Primary Membranous Nephropathy
Clinical trial NCT05398653 · COMPLETED
Trial details
- NCT number
- NCT05398653
- Sponsor
- Beijing Mabworks Biotech Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-24
- Primary completion
- 2025-03-04
- Enrollment
- 94
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.